Since the biochemical, cytological, and molecular data demonstrated AR as the prime target of VNPP433-3β, we sought to evaluate the effect of VNPP433-3β in AR-overexpressing tumor xenografts in vivo. This evidence concerns the gene AR and neoplasm.